561 - 570 of 6451 Results
Title
Year
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page: e2257End Page: e2257Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 19
-
OPENTitle: The Parkinson’s Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measuresJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 2Start Page: fcaa046End Page: fcaa046Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa046Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/2/fcaa046/35118141/fcaa046.pdfCitation Count: 13
-
OPENTitle: Pyk2 overexpression in postsynaptic neurons blocks amyloid β1–42-induced synaptotoxicity in microfluidic co-culturesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 2Start Page: fcaa139End Page: fcaa139Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa139Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/2/fcaa139/36458145/fcaa139.pdfCitation Count: 27
-
OPENTitle: Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page: fcab109End Page: fcab109Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab109Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab109/41723515/fcab109.pdfCitation Count: 49
-
OPENTitle: Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson’s disease depends on tremor severity and symptom durationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 3Start Page: fcab165End Page: fcab165Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab165Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/3/fcab165/39604424/fcab165.pdfCitation Count: 11
-
OPENTitle: Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 1Start Page: fcab293End Page: fcab293Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab293Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/1/fcab293/42475382/fcab293.pdfCitation Count: 27
-
OPENTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385510Citation Count: 33
-
OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 151
-
OPENTitle: Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s diseaseJournal Name: Brain PathologyPublisher: WileyVol: 30Issue #: 4Start Page: 794End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.12842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12842Citation Count: 15
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: http://doi.org/10.1016/j.brainres.2011.06.057Citation Count: 78